Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5,500 CLP
12.49 T CLP
75.09 T CLP
2.40 B
About Johnson & Johnson
Sector
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Founded
1887
FIGI
BBG00YFST5R5
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
JNJ major support...must hold, buying a few shares here
the inverse head and shoulder failed, NYSE:JNJ is now close to the bottom of this multi-year flag...
it must hold or a bigger flush may occur, given the stability of the company, I am leaning towards a bounce and buying a few shares for the long term
no options till price close above the 9/21
Gamma peak on 145 indicating up direction Gamma peak on 145 indicating up direction , its demand and support area with MACD Histogram Divergence seen its supposed to go toward 148 in case 144/143 will hold
Technical Analysis of Johnson & Johnson Stock (JNJ)This chart for JNJ illustrates a technical setup within a descending channel. Key Fibonacci retracement levels (38.2%, 50%, and 61.8%) are highlighted, indicating potential zones of support and resistance. The analysis suggests a three-part buying strategy: an initial purchase at the current market
Johnson & Johnson | JNJ | Long at $146.00Johnson & Johnson NYSE:JNJ is strong (but highly controversial) company with anticipated earnings growth on the horizon. With a P/E of 23x, steady dividend growth record, low debt, and expected increased cashflow, the future is optimistic for NYSE:JNJ if they can stay out of the shady spotlight.
$JNJ Call verticalNYSE:JNJ has been declining for some time. Currently the bullish divergence is everywhere. The price is also outside the BB band. I think there is a very good change for the price to move up in the coming days.
I bought Jan. 2025 $150/$155 call vertical for $2.33
I will double my money if the stoc
JNJ Long consolidation..potential breakoutNYSE:JNJ has been consolidating for over 2 years on this range now:
* monthly bull flag
* forming the right shoulder of an IHS on weekly chart (can even see it on the monthly)
* healthcare sector oversold, so can see a bounce
a bounce could push JNJ to test the upper trendline at 165-166.
The IHS
$150 support for JNJ?$150 was a popular area from April to July. Once it finally broke through, it went to its high for the year of $168. Even after a good earning report, JNJ has been on the decline since. It hopefully found support at $150. It stayed in the support range for two days and immediately had the bullis
JNJThe JNJ stock is in a strong downtrend and has bounced back four times from it. We expect the stock to make a new low below $140, with a stop loss if it breaks above the last high at $167.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where JNJCL is featured.
Frequently Asked Questions
The current price of JNJCL is 154,000 CLP — it hasn't changed in the past 24 hours. Watch JOHNSON & JOHNSON stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange JOHNSON & JOHNSON stocks are traded under the ticker JNJCL.
JNJCL stock has risen by 0.24% compared to the previous week, the month change is a 0.24% rise, over the last year JOHNSON & JOHNSON has showed a 10.76% increase.
We've gathered analysts' opinions on JOHNSON & JOHNSON future price: according to them, JNJCL price has a max estimate of 212,871.29 CLP and a min estimate of 157,425.74 CLP. Watch JNJCL chart and read a more detailed JOHNSON & JOHNSON stock forecast: see what analysts think of JOHNSON & JOHNSON and suggest that you do with its stocks.
JNJCL reached its all-time high on Jul 12, 2022 with the price of 177,790 CLP, and its all-time low was 115,030 CLP and was reached on Mar 11, 2021. View more price dynamics on JNJCL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JNJCL stock is 5.56% volatile and has beta coefficient of 0.00. Track JOHNSON & JOHNSON stock price on the chart and check out the list of the most volatile stocks — is JOHNSON & JOHNSON there?
Today JOHNSON & JOHNSON has the market capitalization of 347.14 T, it has increased by 0.16% over the last week.
Yes, you can track JOHNSON & JOHNSON financials in yearly and quarterly reports right on TradingView.
JOHNSON & JOHNSON is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
JNJCL earnings for the last quarter are 2.18 K CLP per share, whereas the estimation was 1.99 K CLP resulting in a 9.68% surprise. The estimated earnings for the next quarter are 2.01 K CLP per share. See more details about JOHNSON & JOHNSON earnings.
JOHNSON & JOHNSON revenue for the last quarter amounts to 20.26 T CLP, despite the estimated figure of 19.99 T CLP. In the next quarter, revenue is expected to reach 22.33 T CLP.
JNJCL net income for the last quarter is 2.43 T CLP, while the quarter before that showed 4.42 T CLP of net income which accounts for −45.10% change. Track more JOHNSON & JOHNSON financial stats to get the full picture.
Yes, JNJCL dividends are paid quarterly. The last dividend per share was 1.22 K CLP. As of today, Dividend Yield (TTM)% is 3.39%. Tracking JOHNSON & JOHNSON dividends might help you take more informed decisions.
JOHNSON & JOHNSON dividend yield was 3.00% in 2023, and payout ratio reached 84.93%. The year before the numbers were 2.52% and 66.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 28, 2024, the company has 131.90 K employees. See our rating of the largest employees — is JOHNSON & JOHNSON on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JOHNSON & JOHNSON EBITDA is 26.02 T CLP, and current EBITDA margin is 34.82%. See more stats in JOHNSON & JOHNSON financial statements.
Like other stocks, JNJCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JOHNSON & JOHNSON stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JOHNSON & JOHNSON technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JOHNSON & JOHNSON stock shows the buy signal. See more of JOHNSON & JOHNSON technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.